Home Your basket
• Moderate leukocyte infilt...
   Price 10.50 €
• The ultra-rapid cinematog...
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Facial nerve monitoring d...
   Price 12.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Airbag and hearing loss: ...
   Price 8.50 €
• Teratoma of the parotid g...
   Price 5.50 €
• Difficult blepharoplastie...
   Price 10.50 €
• Feasibility study of sept...
   Price 10.50 €
• Bilateral facial nerve pa...
   Price 5.50 €
• Implementation of the Eur...
   Price 10.50 €
• Congenital cholesteatoma ...
   Price 5.50 €
• Auditory screening in neo...
   Price 8.50 €
• The uses of computer-assi...
   Price 10.50 €
• Post-operative complicati...
   Price 10.50 €
• Stapedotomy and anatomica...
   Price 5.50 €
• Using the superficial tem...
   Price 10.50 €
• Reconstruction of the ant...
   Price 8.50 €
• Neck masses in children: ...
   Price 14.00 €
• Implication of mitochondr...
   Price 10.50 €
• Assessing efficacy of voi...
   Price 5.50 €
• Role and importance of pH...
   Price 12.00 €
• Herniation of the temporo...
   Price 12.50 €
• Artistic anatomy of the n...
   Price 8.50 €
• A survey of current wound...
   Price 5.50 €
• The “Deglutition Handicap...
   Price 10.50 €
• A sphenoidal mucocele wit...
   Price 8.50 €
• Transverse maxillary defi...
   Price 8.50 €
• Treatment and rehabilitat...
   Price 10.50 €
• Eagle’s syndrome: A case ...
   Price 10.50 €
• Rhinophyma in a black afr...
   Price 5.50 €
• Acute rhinosinusitis in a...
   Price 8.50 €
• Oropharyngeal reconstruct...
   Price 10.50 €
• Melanotic neuroectodermal...
   Price 8.50 €
• The Bell Labs contributio...
   Price 12.50 €
• A study of the effects of...
   Price 14.00 €
• Seven cases of inverted n...
   Price 10.50 €
• Alternative clinical mana...
   Price 10.50 €
• Floating stapes footplate...
   Price 12.00 €

Total Order 364.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2006 o

OTOLOGY

Amphicrine adenoma of the middle ear: Three cases reports and a review of the literature


Authors : K. Aubry, J. P. Sauvage, S. Puyraud (Limoges)

Ref. : Rev Laryngol Otol Rhinol. 2006;127,3:145-149.

Article published in french
Downloadable PDF document french



Summary : Amphicrine adenoma is an extremely rare tumor of the middle ear. We report three cases obtained over a twenty year period. The aim of this study is to discuss our clinical cases and review the literature. Materials and methods: Three cases of middle ear amphicrine tumour were reviewed. Results: During a 10 year period (1986-2006) three cases of middle ear amphicrine tumour were treated at our unit (2 male, 1 female). The presenting complaint was hearing loss in all 3 cases. Amphicrine adenoma is diagnosed by an immuno-histological examination of pathological specimens. Differential diagnosis can be difficult and one individual was initially treated as an adenocarcinoma by radiotherapy. This patient succumbed to cerebral mycosis two years post-radiotherapy. The other two patients have no evidence of recurrence eight and nine years post treatment. Conclusion: Historically, differential diagnosis between amphicrine adenoma and adenocarcinoma of the middle ear has been very difficult. Carcinoid tumour is considered to be a more agressive form of amphicrine adenoma. Tumour progression is through loco regional invasion. Complete excision by surgical management with long term follow up is the treatment of choice.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE